MCRA is a leading global CRO & advisory firm with deep industry experience and integration of the following core value creators: clinical research, global regulatory, reimbursement, quality assurance, healthcare compliance, and cybersecurity.

Who We Are
MCRA is the leading industry-specialized, multi-service, employee-based, integrated business that assists clients in the entire technology life cycle, from research and development, through commercialization. Our team provides services to a wide range of organizations in the healthcare industry, including start-ups to the world's leading healthcare organizations, as well as all types of financial investors, global manufacturers, and individuals.

Industry Specialization
MCRA’s core clientele consists of all arenas of medical devices, with a concentrated focus on neuro-musculoskeletal healthcare; this includes all industry sub-niches that involve orthopedic, cardiology, diagnostic imaging, sports medicine, tissue regeneration, biologics/orthobiologics/biomaterials, orthotic/prosthetic, wound care, invitro diagnostics, and imaging/software devices.

Core Values
MCRA's ability to utilize our industry know-how for purposes of creating value and mitigating risk helps our clients achieve their product development and commercialization goals. MCRA's suite of integrated advisory services helps augment our customers' capabilities and processes, as well as ensure their ability to overcome regulatory and reimbursement hurdles.

Our Difference
MCRA’s more than 150 years of combined expertise lies in clinical research, clinical reimbursement, regulatory and compliance providing our clients with a unique 360 degree integrated perspective. We believe that MCRA's heritage of combining its integrated services in clinical trials has allowed for us to create a proprietary system.

Affiliate Partners
MCRA has several partners we work with and recommend as it relates to assisting companies with successful commercialization strategies both pre- and post-commercialization for medical device, biologic, and combination products.